Overview

Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage

Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how much gabapentin will reduce headaches associated with subarachnoid hemorrhage (SAH) and to reduce the amount of narcotic pain medication prescribed.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Gabapentin
gamma-Aminobutyric Acid